369 related articles for article (PubMed ID: 9391046)
1. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.
Donne DG; Viles JH; Groth D; Mehlhorn I; James TL; Cohen FE; Prusiner SB; Wright PE; Dyson HJ
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13452-7. PubMed ID: 9391046
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of Syrian hamster prion protein rPrP(90-231).
Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
[TBL] [Abstract][Full Text] [Related]
3. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics.
Viles JH; Donne D; Kroon G; Prusiner SB; Cohen FE; Dyson HJ; Wright PE
Biochemistry; 2001 Mar; 40(9):2743-53. PubMed ID: 11258885
[TBL] [Abstract][Full Text] [Related]
4. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform.
James TL; Liu H; Ulyanov NB; Farr-Jones S; Zhang H; Donne DG; Kaneko K; Groth D; Mehlhorn I; Prusiner SB; Cohen FE
Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10086-91. PubMed ID: 9294167
[TBL] [Abstract][Full Text] [Related]
5. NMR structure of the mouse prion protein domain PrP(121-231).
Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.
O'Sullivan DB; Jones CE; Abdelraheim SR; Brazier MW; Toms H; Brown DR; Viles JH
Protein Sci; 2009 Feb; 18(2):410-23. PubMed ID: 19173221
[TBL] [Abstract][Full Text] [Related]
7. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
Hornemann S; Glockshuber R
J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
[TBL] [Abstract][Full Text] [Related]
8. Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.
Gill AC; Ritchie MA; Hunt LG; Steane SE; Davies KG; Bocking SP; Rhie AG; Bennett AD; Hope J
EMBO J; 2000 Oct; 19(20):5324-31. PubMed ID: 11032800
[TBL] [Abstract][Full Text] [Related]
9. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
[TBL] [Abstract][Full Text] [Related]
10. Mapping the prion protein using recombinant antibodies.
Williamson RA; Peretz D; Pinilla C; Ball H; Bastidas RB; Rozenshteyn R; Houghten RA; Prusiner SB; Burton DR
J Virol; 1998 Nov; 72(11):9413-8. PubMed ID: 9765500
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations of human prion protein: importance of correct treatment of electrostatic interactions.
Zuegg J; Gready JE
Biochemistry; 1999 Oct; 38(42):13862-76. PubMed ID: 10529232
[TBL] [Abstract][Full Text] [Related]
12. Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.
Kaneko K; Peretz D; Pan KM; Blochberger TC; Wille H; Gabizon R; Griffith OH; Cohen FE; Baldwin MA; Prusiner SB
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11160-4. PubMed ID: 7479957
[TBL] [Abstract][Full Text] [Related]
13. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
[TBL] [Abstract][Full Text] [Related]
14. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
15. Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation.
Alvarez-Martinez MT; Torrent J; Lange R; Verdier JM; Balny C; Liautard JP
Biochim Biophys Acta; 2003 Feb; 1645(2):228-40. PubMed ID: 12573253
[TBL] [Abstract][Full Text] [Related]
16. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
17. Structure of the flexible amino-terminal domain of prion protein bound to a sulfated glycan.
Taubner LM; Bienkiewicz EA; Copié V; Caughey B
J Mol Biol; 2010 Jan; 395(3):475-90. PubMed ID: 19913031
[TBL] [Abstract][Full Text] [Related]
18. Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc?
Kuwata K; Li H; Yamada H; Legname G; Prusiner SB; Akasaka K; James TL
Biochemistry; 2002 Oct; 41(41):12277-83. PubMed ID: 12369815
[TBL] [Abstract][Full Text] [Related]
19. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
